BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1704323)

  • 1. Characterization of EIAV immunogenicity during persistent infections: humoral responses and antigen targets.
    Montelaro RC; Ball JM; Issel CJ
    Dev Biol Stand; 1990; 72():19-30. PubMed ID: 1704323
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
    Zhang W; Auyong DB; Oaks JL; McGuire TC
    Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of precipitating antibody in equine infectious anemia by concentrated virus antigen.
    Nakajima H; Ushimi C
    Natl Inst Anim Health Q (Tokyo); 1972; 12(2):47-53. PubMed ID: 4340682
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis of equine infectious anemia lentivirus disease.
    McGuire TC; O'Rourke KI; Perryman LE
    Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of a persistent retrovirus infection--equine infectious anemia.
    McGuire TC; Crawford TB
    Adv Vet Sci Comp Med; 1979; 23():137-59. PubMed ID: 95154
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation of hemagglutinating antigen of equine infectious anemia virus from infected equine leukocyte cultures.
    Sentsui H; Kono Y
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):39-40. PubMed ID: 206841
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
    McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
    Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
    Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
    Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus.
    Grund CH; Lechman ER; Issel CJ; Montelaro RC; Rushlow KE
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():657-62. PubMed ID: 7510329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses in horses infected with equine infectious anemia virus adapted to tissue culture.
    Gutekunst DE; Becvar CS
    Am J Vet Res; 1979 Jul; 40(7):974-7. PubMed ID: 228570
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural proteins of equine infectious anemia virus and their antigenic activity.
    Nishimura M; Nakajima H
    Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a cell membrane antigen by equine infectious anemia virus.
    McGuire TC; Crawford TB
    Am J Vet Res; 1978 Mar; 39(3):385-6. PubMed ID: 205145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to herpesvirus types 1 and 2, arteritis and infectious anemia viral antigens in equine serum.
    McGuire TC; Crawford TB; Henson JB
    Am J Vet Res; 1974 Feb; 35(2):181-5. PubMed ID: 4360338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.